Care Pathway for Cancer Survivorship in Korea: Trend of Breast Cancer Pathway from 2003 to 2010.
10.4258/hir.2017.23.2.119
- Author:
Hwa Jeong SEO
1
;
Dong Yong NOH
Author Information
1. Medical Informatics and health Technology (MIT), Department of Healthcare Management, College of Social Science, Gachon University, Seongnam, Korea.
- Publication Type:Original Article
- Keywords:
Breast Neoplasms;
Survival Rate;
Critical Pathways;
Cohort Studies;
Postoperative Care
- MeSH:
Breast Neoplasms*;
Breast*;
Chronic Disease;
Cohort Studies;
Critical Pathways;
Hospice Care;
Humans;
Incidence;
Korea*;
Postoperative Care;
Survival Rate*;
Survivors
- From:Healthcare Informatics Research
2017;23(2):119-125
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: The survival rate of cancer patients has exceeded 60%. Although cancer survivors may die of other diseases except cancer, the health management system including chronic disease prevention-management for cancer survivors, has not been established in the diverse aspects. Therefore, services according to care pathway of cancer patients need to be provided through a support system based on a platform concept that can be used to meet patient needs in various ways. METHODS: A sample cohort database (2002–2010) of approximately 1 million persons—2% of the whole nation (50 million)—was used to estimate cancer survivors through a principal care pathway for cancer management. The sample cohort database was built to estimate the number of breast cancer survivors in the five stage: ‘Diagnosis and treatment,’‘Supportive care,’‘Monitoring,’‘Progress illness,’ and ‘Hospice care’. In this way, the scale of breast cancer survivors was estimated. RESULTS: There were 330 (9.8%) cases of the incidence of cancer in 2010 in the ‘Diagnosis and treatment.’ Among the cases of the incidence of cancer in the previous year, the number of one-year survivors was 328 (9.7%); these were included in the category ‘Supportive care.’ In the ‘Monitoring’ category, 2,593 (76.9%) who maintained health lives were included. A total of 84 (2.5%) survivors were checked to identify an ongoing disease; these were included in the category ‘Progress illness.’ In the category ‘Hospice care,’ 36 (1.1%) end-stage cancer patients requiring hospice care were included. CONCLUSIONS: We established a care pathway by survival stage in order to fulfill prevention and health management services post-treatment management steps.
